IL22 and autoimmune hepatitis: Additionally, it increases anti-inflammatory cytokines, such as IL-22, effectively inhibiting the interaction between LPS and TLR4 and reducing hepatic inflammation pathways (Jiang et al., 2023), thus providing protection against AIH.